Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis
Background and aims Statin therapy is administered to patients with high cardiovascular risk.
These patients are also at risk for severe course of coronavirus disease 2019 (COVID-19). …
These patients are also at risk for severe course of coronavirus disease 2019 (COVID-19). …
Procalcitonin to reduce long-term infection-associated adverse events in sepsis. A randomized trial
…, V Apostolopoulos, D Petrou, T Nitsotolis… - American Journal of …, 2021 - atsjournals.org
Rationale: Although early antimicrobial discontinuation guided by procalcitonin (PCT) has
shown decreased antibiotic consumption in lower respiratory tract infections, the outcomes in …
shown decreased antibiotic consumption in lower respiratory tract infections, the outcomes in …
[HTML][HTML] Early start of oral clarithromycin is associated with better outcome in COVID-19 of moderate severity: the ACHIEVE open-label single-arm trial
…, P Tsiamalos, K Syrigos, G Chrysos, T Nitsotolis… - Infectious Diseases and …, 2021 - Springer
Introduction The anti-inflammatory effect of macrolides prompted the study of oral clarithromycin
in moderate COVID-19. Methods An open-label non-randomized trial in 90 patients with …
in moderate COVID-19. Methods An open-label non-randomized trial in 90 patients with …
New perspectives in the antibiotic treatment of mechanically ventilated patients with infections from Gram-negatives
M Karvouniaris, K Pontikis, T Nitsotolis… - Expert Review of Anti …, 2021 - Taylor & Francis
Introduction: Ventilator-associated pneumonia (VAP) is a common and potentially fatal
complication of mechanical ventilation that is often caused by multidrug-resistant (MDR) Gram-…
complication of mechanical ventilation that is often caused by multidrug-resistant (MDR) Gram-…
Prone positioning in patients with COVID-19: Analysis of multicenter registry data and meta-analysis of aggregate data
Background/Aim: Evidence suggests a beneficial effect of prone positioning (PP) in COVID-19.
Materials and Methods: Meta-analysis of individual (7 investigators’ groups) and …
Materials and Methods: Meta-analysis of individual (7 investigators’ groups) and …
Sagittal abdominal diameter may effectively predict future complications and increased mortality in intensive care unit patients with severe sepsis
A Chalkias, T Nitsotolis, A Papalexandrou, S Mikros… - Journal of Critical …, 2013 - Elsevier
Purpose To investigate whether increased visceral adipose tissue is a risk factor for
increased morbidity and mortality in intensive care patients with severe sepsis. Materials and …
increased morbidity and mortality in intensive care patients with severe sepsis. Materials and …
Comparison of monotherapy versus combination antihypertensive therapy in elderly patients with essential hypertension
…, S Kokkoris, S Gerakari, S Mikros, T Nitsotolis… - …, 2008 - journals.sagepub.com
Authors sought to compare the efficacy of monotherapy versus combination antihypertensive
therapy in elderly patients. Patients in this study, aged 65 to 85 years, were divided into 4 …
therapy in elderly patients. Patients in this study, aged 65 to 85 years, were divided into 4 …
Early occurrence of adverse events in hospitalized patients with COVID-19 and beneficial effect of anticoagulation
…, K Dimakou, G Tsoukalas, K Athanasiou, T Nitsotolis… - in vivo, 2022 - iv.iiarjournals.org
Background/Aim: This study analyzed the characteristics of patients with COVID-19 with
major events during the first days of hospitalization. Patients and Methods: This is a …
major events during the first days of hospitalization. Patients and Methods: This is a …
Comparison of Integrase Strand Transfer Inhibitors (INSTIs) and Protease-Boosted Inhibitors (PIs) on the Reduction in Chronic Immune Activation in a Virally …
T Nitsotolis, KG Kyriakoulis, A Kollias… - Medicina, 2024 - mdpi.com
Background and Objectives: The success of combined antiretroviral therapy (cART) has led
to a dramatic improvement in the life expectancy of people living with HIV (PLWH). However, …
to a dramatic improvement in the life expectancy of people living with HIV (PLWH). However, …
Oral clarithromycin in COVID-19 of moderate severity: the ACHIEVE open-label trial using concurrent matched comparators
…, P Tsiamalos, K Syrigos, G Chrysos, T Nitsotolis… - MedRxiv, 2020 - medrxiv.org
Background Clarithromycin clinical efficacy has not been described in COVID-19. Research
question Is oral clarithromycin beneficial for treating patients diagnosed with COVID-19? …
question Is oral clarithromycin beneficial for treating patients diagnosed with COVID-19? …